Close
CDMO Safety Testing 2026
Novotech

To Accredit Medical Devices In The UK, MHRA Selects DEKRA

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Quantum Simulation Improving Molecular Drug Design

Advancements in quantum mechanical modeling are revolutionizing the way pharmaceutical scientists engineer new therapeutic agents. By providing a high-fidelity simulation of electronic structures and molecular dynamics, these tools enable the precise design of compounds tailored to specific biological targets. This transition from traditional experimental screening to digital molecular architecture is accelerating the development of highly potent and selective medicines, fundamentally changing the landscape of pharmaceutical innovation and computational chemistry.

Quantum Algorithms Transforming Pharma Data Analysis

The pharmaceutical industry is entering a new era of data-driven discovery where traditional analytical methods are being augmented by quantum-enhanced logic. By utilizing specialized mathematical frameworks, researchers can now process massive, high-dimensional datasets with a speed and depth that classical systems cannot match. This transformation is streamlining clinical workflows, optimizing drug-to-patient matching, and revealing hidden patterns within biological data, paving the way for more efficient research and faster therapeutic breakthroughs.

Quantum Computing Accelerating Drug Discovery Models

Integrating quantum mechanics into pharmaceutical research marks a paradigm shift in how scientists identify and develop therapeutic compounds. By leveraging the principles of superposition and entanglement, researchers can simulate molecular interactions with unprecedented accuracy, bypassing the limitations of traditional binary computation. This evolution promises to drastically reduce the time and capital required to bring life-saving drugs to market while opening new doors for treating complex diseases that have long remained elusive.
- Advertisement -

The three current UK-approved bodies have been joined by DEKRA Certification UK, according to the Medicines and Healthcare Products Regulatory Agency (MHRA), enhancing the UK’s capacity to handle conformity evaluations for medical devices. As the first institution to accomplish the new designation procedure, DEKRA is now authorised to carry out evaluations of general medical equipment, or Part II designation.

An approved body is a group that has been given permission by the MHRA to check whether manufacturers and their medical devices meet the requirements set out in the UK Medical Devices Regulations 2002. Manufacturers must submit an application to a UK-approved organisation, with the exception of the absolute lowest-risk devices. Their products can only be sold in England, Wales, and Scotland after receiving UK Conformity Assessed (UKCA) certification.

The goal of the MHRA’s thorough assessment process is to make sure that any organisations that wish to certify medical devices are stable, capable of conducting fair and objective evaluations, have a suitable quality management process in place to support them, have the resources to conduct the evaluations, and have mechanisms and ongoing credentialsย in place to comply with the relevant regulatory requirements. The recognised authority will give the necessary certification following an adequate evaluation, enabling producers to apply the UKCA logo to their products before releasing them onto the market.

This is a huge milestone in their commitment to ensuring individuals all across the UK get access to the high-quality medical equipment they need to protect their health, said Dr. Laura Squire who is the chief healthcare quality and access officer at MHRA.

The growth of the UK’s medical device regulatory framework depends on approved organisations, which play a crucial role in the supply of medical equipment. The teams have put in a tremendous amount of effort to get to this point, and this has been a huge piece of work, she continued.

An additional six organisations are currently through the assessment process, while numerous other organisations are actively engaged in the process of getting prepared to send their initial submission.

Latest stories

Related stories

Quantum Simulation Improving Molecular Drug Design

Advancements in quantum mechanical modeling are revolutionizing the way pharmaceutical scientists engineer new therapeutic agents. By providing a high-fidelity simulation of electronic structures and molecular dynamics, these tools enable the precise design of compounds tailored to specific biological targets. This transition from traditional experimental screening to digital molecular architecture is accelerating the development of highly potent and selective medicines, fundamentally changing the landscape of pharmaceutical innovation and computational chemistry.

Quantum Algorithms Transforming Pharma Data Analysis

The pharmaceutical industry is entering a new era of data-driven discovery where traditional analytical methods are being augmented by quantum-enhanced logic. By utilizing specialized mathematical frameworks, researchers can now process massive, high-dimensional datasets with a speed and depth that classical systems cannot match. This transformation is streamlining clinical workflows, optimizing drug-to-patient matching, and revealing hidden patterns within biological data, paving the way for more efficient research and faster therapeutic breakthroughs.

Quantum Computing Accelerating Drug Discovery Models

Integrating quantum mechanics into pharmaceutical research marks a paradigm shift in how scientists identify and develop therapeutic compounds. By leveraging the principles of superposition and entanglement, researchers can simulate molecular interactions with unprecedented accuracy, bypassing the limitations of traditional binary computation. This evolution promises to drastically reduce the time and capital required to bring life-saving drugs to market while opening new doors for treating complex diseases that have long remained elusive.

Glass vs Polymer: Choosing the Right Material for Parenteral Packaging

In the pharmaceutical industry, material selection plays a critical...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป